Bone Medical completes merger with Revenir

By Melissa Trudinger
Monday, 23 August, 2004

UK biotech company Bone Limited has completed its merger with Perth-based listed property management company Revenir (ASX: REV) after a successful capital raising of $2.5 million closed oversubscribed earlier in the month.

The company, which will be known as Bone Medical, is expected to start trading on August 31, 2004 under the stock symbol BNE.

Heart muscle regeneration genes mapped

Researchers have uncovered insights into how stem cells develop and mature into heart muscle...

The cause of 2022's mpox outbreak revealed

Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...

New gene therapy treats liver disorder in growing children

Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...

Content from other channels on our network

$2.5m to double circuit breaker production in Adelaide

ARENA announces new clean energy startup funding

Peak body wants engineering expertise at the heart of the AI future

$26 million to fund new Australian iron technology

Yokogawa launches cyber resilience centre for SE Asia and Oceania

Nurse-led infection control training program

Does frailty hold the key to early dementia diagnosis?

Tiny gold particles power golden staph colour test

The cost of not cleaning: how to reduce infections and save money

WA's women's, newborn and children's model remains a "major missed opportunity", doctors say

$2.5m to double circuit breaker production in Adelaide

Long-term water security project proposed for Hunter region

Engineering sustainability from the ground up at Selfs Point STP

Complex solar installation for Adelaide wine venue

Australia's data centre plans can become a blueprint for the world